Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition

Future directions in the treatment of osteosarcoma

(2016) Michael W. Bishop et al.   CURRENT OPINION IN PEDIATRICS

Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro

(2016) M. A. Hoda et al.   MOLECULAR CANCER THERAPEUTICS

Update on Survival in Osteosarcoma

(2016) Megan E. Anderson   ORTHOPEDIC CLINICS OF NORTH AMERICA

Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis

(2016) Dávid Kovács et al.   Scientific Reports

The naturally born fusariotoxin enniatin B and sorafenib exert synergistic activity against cervical cancer in vitro and in vivo

(2015) Rita Dornetshuber-Fleiss et al.   BIOCHEMICAL PHARMACOLOGY

Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling

(2015) Bruno Christian Koehler et al.   BMC CANCER

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

(2015) Michael S. Isakoff et al.   JOURNAL OF CLINICAL ONCOLOGY

EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance

(2015) Florian Sevelda et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Effect of PI3K-mediated autophagy in human osteosarcoma MG63 cells on sensitivity to chemotherapy with cisplatin

(2015) Xu-Dong Miao et al.   Asian Pacific Journal of Tropical Medicine

Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46

(2014) U. Jungwirth et al.   MOLECULAR CANCER THERAPEUTICS

Integrin inhibition promotes atypical anoikis in glioma cells

(2014) M Silginer et al.   Cell Death & Disease

Autophagy modulates cell migration and β1 integrin membrane recycling

(2013) Véronique Tuloup-Minguez et al.   CELL CYCLE

Synergistic Anticancer Activity of Arsenic Trioxide with Erlotinib Is Based on Inhibition of EGFR-Mediated DNA Double-Strand Break Repair

(2013) K. Kryeziu et al.   MOLECULAR CANCER THERAPEUTICS

p21 overexpression sensitizes osteosarcoma U2OS cells to cisplatin via evoking caspase-3 and Bax/Bcl-2 cascade

(2013) Yong Ding et al.   TUMOR BIOLOGY

Regulation of Cell Adhesion and Migration by Kindlin-3 Cleavage by Calpain

(2012) Yongzhong Zhao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Gallium compound GaQ3-induced Ca2+ signalling triggers p53-dependent and -independent apoptosis in cancer cells

(2011) Rajan Gogna et al.   BRITISH JOURNAL OF PHARMACOLOGY

Calpains promote α2β1 integrin turnover in nonrecycling integrin pathway

(2011) Nina Rintanen et al.   MOLECULAR BIOLOGY OF THE CELL

Functional and biological analysis of Bcl-xL expression in human osteosarcoma

(2010) Zhao-Xia Wang et al.   BONE

Prognostic markers in osteosarcoma

(2010) Sameer Bakhshi et al.   Expert Review of Anticancer Therapy

The gallium complex KP46 exerts strong activity against primary explanted melanoma cells and induces apoptosis in melanoma cell lines

(2009) Seied Mojtaba Valiahdi et al.   MELANOMA RESEARCH

Advances in developing tris(8-quinolinolato)gallium(iii) as an anticancer drug: critical appraisal and prospects

(2009) Andrei R. Timerbaev   Metallomics